Three lncRNAs are potential predictive indicators of the effectiveness of vemurafenib therapy in persons with melanoma: IGF2 antisense (IGF2AS), MEG3, along with zinc finger AE-binding homeobox 2-natural antisense transcript (Zeb2NAT) (72). This evidence concerns the gene IGF2-AS and melanoma.